SCHEMBL21990728

SCHEMBL21990728

O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].[Al+3].[Gd+3]

nearest known ligand 0.67

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
CA5A P35218 1/20 0.46
CA5B Q9Y2D0 1/20 0.46
TSHR P16473 3/20 0.39
ALDH1A1 P00352 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
HPGD P15428 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL66249 0.94 MEN1 (0.75) MEN1KMT2ACA5ACA5BTSHR
SCHEMBL6514209 0.94 MEN1 (0.75) MEN1KMT2ACA5ACA5BTSHR
SCHEMBL21178 0.94 MEN1 (0.75) MEN1KMT2ACA5ACA5BTSHR
SCHEMBL11122695 0.88 MEN1 (0.67) MEN1KMT2ACA5ACA5BTSHR
Water SCHEMBL21625339 0.88 MEN1 (0.67) MEN1KMT2ACA5ACA5BTSHR
SCHEMBL25187157 0.88 MEN1 (0.67) MEN1KMT2ACA5ACA5BTSHR
SCHEMBL20608390 0.88 MEN1 (0.67) MEN1KMT2ACA5ACA5BTSHR
SCHEMBL22518805 0.88 MEN1 (0.67) MEN1KMT2ACA5ACA5BTSHR
SCHEMBL8513356 0.88 MEN1 (0.67) MEN1KMT2ACA5ACA5BTSHR
Water SCHEMBL4370443 0.88 MEN1 (0.67) MEN1KMT2ACA5ACA5BTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111270217-B Coating system comprising a penetrating coating and a reactive phase spray formulation coating 通用电气公司 2022-08-30 CN claimed
EP-3663432-B1 COATING SYSTEMS INCLUDING INFILTRATION COATINGS AND REACTIVE PHASE SPRAY FORMULATION COATINGS GEN ELECTRIC (US) 2021-07-14 EP claimed
US-20260132513-A1 COATING SYSTEMS INCLUDING INFILTRATION COATINGS AND REACTIVE PHASE SPRAY FORMULATION COATINGS GENERAL ELECTRIC CO (US) 2026-05-14 US disclosed
US-12215428-B2 Coating systems including infiltration coatings and reactive phase spray formulation coatings GENERAL ELECTRIC COMPANY (US) 2025-02-04 US disclosed
US-20240247378-A1 COATING SYSTEMS INCLUDING INFILTRATION COATINGS AND REACTIVE PHASE SPRAY FORMULATION COATINGS GENERAL ELECTRIC COMPANY 2024-07-25 US disclosed
US-11946146-B2 Coating systems including infiltration coatings and reactive phase spray formulation coatings GENERAL ELECTRIC COMPANY (US) 2024-04-02 US disclosed
CN-111270217-B Coating system comprising a penetrating coating and a reactive phase spray formulation coating 通用电气公司 2022-08-30 CN disclosed
US-20210277523-A1 COATING SYSTEMS INCLUDING INFILTRATION COATINGS AND REACTIVE PHASE SPRAY FORMULATION COATINGS GENERAL ELECTRIC COMPANY 2021-09-09 US disclosed
EP-3663432-B1 COATING SYSTEMS INCLUDING INFILTRATION COATINGS AND REACTIVE PHASE SPRAY FORMULATION COATINGS GEN ELECTRIC (US) 2021-07-14 EP disclosed
US-11028486-B2 Coating systems including infiltration coatings and reactive phase spray formulation coatings GENERAL ELECTRIC COMPANY (US) 2021-06-08 US disclosed
CN-111270217-A Coating system comprising a penetrating coating and a reactive phase spray formulation coating 通用电气公司 2020-06-12 CN disclosed
EP-3663432-A2 COATING SYSTEMS INCLUDING INFILTRATION COATINGS AND REACTIVE PHASE SPRAY FORMULATION COATINGS General Electric Company (US) 2020-06-10 EP disclosed
US-20200173033-A1 COATING SYSTEMS INCLUDING INFILTRATION COATINGS AND REACTIVE PHASE SPRAY FORMULATION COATINGS GENERAL ELECTRIC COMPANY 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132513-A1 COATING SYSTEMS INCLUDING INFILTRATION COATINGS AND REACTIVE PHASE SPRAY FORMULATION COATINGS ZKSCAN2, GZMB, SP1 MEN1 441/4885KMT2A 1014/4885CA5A 1578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.